Showing 1421-1430 of 5231 results for "".
Update on Human Safety and the Environmental Impact of Physical and Chemical Sunscreen Filters
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-on-human-safety-and-the-environmental-impact-of-physical-and-chemical-sunscreen-filters/20800/What do we know about the effects of these commonly used and important molecules?A First Look at Rotational Fractional Resection
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-first-look-at-rotational-fractional-resection/20383/A new technology offers a fresh approach to treatment of submental contouring.Therapeutics Update: New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/therapeutics-update-new-products-and-pharmacologic-developments/20390/What's Your Priority?
https://practicaldermatology.com/topics/practice-management/whats-your-priority/20309/Prioritization skills are essential, because everything will end up on your plate.Understanding the Legalities of Off-label Use
https://practicaldermatology.com/topics/practice-management/understanding-the-legalities-of-off-label-use/20317/Off-label use is part and parcel of dermatology practice, but confusion about the practice persists. Here's what you should know.Repairing the Ellipse; Resident Salary Update
https://practicaldermatology.com/youngmd-connect/resident-resource-center/repairing-the-ellipse-resident-salary-update/20414/Subcision Plus Sublative Technologies to Treat Acne Scars
https://practicaldermatology.com/topics/general-topics/subcision-plus-sublative-technologies-to-treat-acne-scars/20462/Combining something old and something new to create something skintastic.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20454/Skin Cancer Awareness, Epiduo Data, Impoyz Launch
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-skin-cancer-awareness-epiduo-data-impoyz-launch/18307/Data shed light on patents' attitudes towards kids' sunblock and new findings emerge on melanoma risks. FDA accepts BLA for cemiplimab for advanced SCC and approves Novartis' Tafinlar in combination with Mekinist for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutationsAvoiding Laser and Energy-Based Device Complications
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/avoiding-laser-and-energy-based-device-complications/20564/Knowing how to avoid and effectively manage potential complications is key to success.